Document is current
Any future updates will be listed below
-
Authors
Eddiry, Sanaa
Diene, Gwenaelle
Molinas, Catherine
Salles, Juliette
Auriol, Françoise Conte
Gennero, Isabelle
Bieth, Eric
Skryabin, Boris V.
Rozhdestvensky, Timofey S.
Burnett, Lisa C.
Leibel, Rudolph L.
Tauber, Maithé
Salles, Jean Pierre https://orcid.org/0000-0002-0941-8951
-
Funding
Funding for this research was provided by:
Clinical research Program of Midi-Pyrénées (09004797, NCT01298180, NCT01298180, NCT01298180, NCT01298180, NCT01298180)
Pfizer
Sandoz France
Ipsen Beaufour
Lilly
French association for Prader–Willi Syndrome
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: SNORD116 and growth hormone therapy impact IGFBP7 in Prader–Willi syndrome
Journal Title: Genetics in Medicine
CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41436-021-01185-y
Content Type: article
Copyright: © 2021, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics
